Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhixia Yan Danielsen
Observed name:
Zhixia Y Danielsen
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
ORCID:
0009-0009-0931-6160
Observed ORCID:
0009-0009-0931-6160
OpenAlex ID:
A5019951050
Human radiolabeled mass balance studies supporting the FDA approval of new drugs
2022
·
Anuradha Ramamoorthy
, Girish Bende
, et al.
·
Clinical and Translational Science
·
43
PDF
Polyethylene glycol-functionalized poly (Lactic Acid-co-Glycolic Acid) and graphene oxide nanoparticles induce pro-inflammatory and apoptotic responses in Candida albicans-infected vaginal epithelial cells
2017
·
R. Doug Wagner
, Shemedia J. Johnson
, et al.
·
PLoS ONE
·
29
PDF
Regulatory Considerations in the Approval of Rezafungin (Rezzayo) for the Treatment of Candidemia and Invasive Candidiasis in Adults
2024
·
Heidi L Smith
, Timothy J Bensman
, et al.
·
The Journal of Infectious Diseases
·
21
PDF
Animal pharmacokinetics/pharmacodynamics (PK/PD) infection models for clinical development of antibacterial drugs: lessons from selected cases
2023
·
Jason N Moore
, Lucas Poon
, et al.
·
Journal of Antimicrobial Chemotherapy
·
17
1556. Assessment of Translational In Vitro and Animal Pharmacokinetic–Pharmacodynamic Data Used to Support Drug Development of Recent Tetracycline Derivatives
2019
·
Jason Moore
, Sonia Pahwa
, et al.
·
Open Forum Infectious Diseases
·
1
Human Radiolabeled Mass Balance Studies Supporting New Drugs Approved by FDA Between 2019 and 2023
2026
·
Anuradha Ramamoorthy
, Alana Chen
, et al.
·
Clinical and Translational Science
PDF
Show more works
View as search
Works count:
6
Citation count:
111
H-index:
4
I10-index:
4
Year
Topic
Type